LifeVantage (NASDAQ:LFVN) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS

LifeVantage (NASDAQ:LFVNGet Free Report) released its earnings results on Wednesday. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.08, Zacks reports. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%.

LifeVantage Stock Performance

LFVN traded down $1.00 during trading on Wednesday, reaching $22.74. 486,894 shares of the company traded hands, compared to its average volume of 270,076. LifeVantage has a 12-month low of $5.22 and a 12-month high of $27.38. The firm has a fifty day simple moving average of $18.97 and a 200 day simple moving average of $13.59. The company has a market cap of $284.70 million, a P/E ratio of 71.06 and a beta of 0.84.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.70%. LifeVantage’s dividend payout ratio (DPR) is currently 50.00%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Craig Hallum assumed coverage on shares of LifeVantage in a report on Tuesday, January 14th. They issued a “buy” rating and a $35.00 target price for the company. Lake Street Capital assumed coverage on shares of LifeVantage in a report on Thursday, December 19th. They issued a “buy” rating and a $26.00 target price for the company.

View Our Latest Stock Report on LifeVantage

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Articles

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.